Forecast & Rating3 analysts currently cover NeuroSense Therapeutics - Unit, of which 3 give a positive rating. The average price target is $6.50, about 1334.6% upside from the current price of $0.45. Coverage is limited, so the data is for reference only. Data as of Aug 11, 2026; this does not constitute investment advice.
Aug 11, 2026Price forecast
$6.501334.56%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 9, 2026
Forecast met3.8%
Stock price$0.45
Avg. target$10.2
High target$14
Low target$8
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.